The International Journal of Biomedical Research and Healthcare Innovations (IJBRHI) is committed to promoting research integrity, ethical accountability, editorial independence, and transparency in scholarly publishing.
The journal’s publication ethics framework is informed by the principles of the Committee on Publication Ethics (COPE), recommendations of the International Committee of Medical Journal Editors (ICMJE), and applicable international standards governing biomedical and clinical research.
Authors must submit original, accurate, and ethically conducted research. Methods, procedures, findings, and study limitations must be reported transparently without fabrication or falsification.
Editors evaluate manuscripts fairly and independently based strictly on scientific merit, methodological rigor, and ethical compliance, completely uninfluenced by commercial considerations.
Peer reviewers evaluate manuscripts objectively, confidentially, and within their technical expertise, providing evidence-based feedback and reporting suspected misconduct or ethical concerns.
Authorship must reflect substantial intellectual contributions adhering to ICMJE standards. Guest, gift, and ghost authorship are strictly prohibited. Non-author contributors must be appropriately acknowledged.
| Clinical & Participant Ethics | Human participant studies require Institutional Review Board (IRB) approval, patient informed consent, trial registration, and strict data privacy. Identifiable patient details or images cannot be published without explicit written consent. |
| Plagiarism & Duplication | Plagiarism, unattributed reproduction, duplicate submission, and undisclosed self-plagiarism are strictly prohibited. All manuscripts undergo similarity assessment and contextual editorial evaluation. |
| Data Integrity & Misconduct | Fabrication, falsification, scientific image manipulation, or deceptive statistics are unacceptable. Synthetic datasets must be explicitly declared and never represented as actual empirical clinical observations. |
| Responsible AI Utilization | AI systems cannot be designated as authors. Substantive generative AI use in data analysis, code development, or manuscript drafting must be disclosed. Authors remain fully accountable for all AI-assisted outputs. |
Allegations involving plagiarism, data fabrication, or authorship disputes are investigated confidentially following COPE flowcharts. When appropriate, concerns may be referred to institutional review boards or authorized regulatory authorities.
When post-publication errors or misconduct affect published literature, formal Corrections, Retractions, or Expressions of Concern are issued to preserve the accuracy and integrity of the public scholarly record.
Commitment to Publication Integrity: The International Journal of Biomedical Research and Healthcare Innovations recognizes ethical publishing as fundamental to the advancement of reliable biomedical knowledge and responsible healthcare innovation.